S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   431.69 (+0.15%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   431.69 (+0.15%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   431.69 (+0.15%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   431.69 (+0.15%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
Free Trial

Ascendis Pharma A/S (ASND) News Today

→ Can't believe it's happening again (From Manward Press) (Ad)
Free ASND Stock Alerts
$144.52
-0.71 (-0.49%)
(As of 01:43 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
marketbeat.com logoSequoia Financial Advisors LLC Makes New $732,000 Investment in Ascendis Pharma A/S (NASDAQ:ASND)
marketbeat.com - April 16 at 5:35 AM
marketbeat.com logoRaymond James Financial Services Advisors Inc. Has $1.04 Million Stake in Ascendis Pharma A/S (NASDAQ:ASND)
marketbeat.com - April 15 at 4:27 AM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) Sees Significant Increase in Short Interest
marketbeat.com - April 14 at 1:27 PM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) Stock Position Reduced by Allspring Global Investments Holdings LLC
marketbeat.com - April 14 at 5:37 AM
benzinga.com logoAscendis Pharma's Options Frenzy: What You Need to Know
benzinga.com - April 12 at 2:11 PM
MarketBeat logoAscendis Pharma A/S (NASDAQ:ASND) Given Average Recommendation of "Moderate Buy" by Analysts
americanbankingnews.com - April 9 at 4:58 AM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) Receives Average Recommendation of "Moderate Buy" from Analysts
marketbeat.com - April 9 at 4:56 AM
seekingalpha.com logoWeek In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion
seekingalpha.com - April 7 at 7:52 AM
benzinga.com logoHere's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
benzinga.com - April 4 at 12:42 AM
msn.com logoRoivant announces $1.5B share buyback, positive Phase 2 data
msn.com - April 2 at 1:38 PM
finance.yahoo.com logoBiotech With 520% Sales Growth Nears Next Buy Point
finance.yahoo.com - April 2 at 1:38 PM
marketbeat.com logoJPMorgan Chase & Co. Boosts Ascendis Pharma A/S (NASDAQ:ASND) Price Target to $167.00
marketbeat.com - April 2 at 11:15 AM
marketbeat.com logoAscendis Pharma A/S's (ASND) "Overweight" Rating Reiterated at Cantor Fitzgerald
marketbeat.com - April 1 at 9:10 AM
finance.yahoo.com logoAre Medical Stocks Lagging AdaptHealth (AHCO) This Year?
finance.yahoo.com - March 22 at 8:25 PM
finance.yahoo.com logoTwo Health Care Stocks Outperform S&P 500, Offer Entries
finance.yahoo.com - March 22 at 8:25 PM
finance.yahoo.com logoAscendis Pharma A/S (ASND) Rose on Positive Trial Results
finance.yahoo.com - March 22 at 8:22 AM
marketbeat.com logoWells Fargo & Company Boosts Ascendis Pharma A/S (NASDAQ:ASND) Price Target to $260.00
marketbeat.com - March 18 at 6:53 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: aTyr Pharma (LIFE), Conmed (CNMD) and Ascendis Pharma (ASND)
markets.businessinsider.com - March 15 at 12:52 PM
markets.businessinsider.com logoBuy Rating Affirmed for Ascendis Pharma Amid Favorable Market Dynamics and Strong TransCon PTH Outlook
markets.businessinsider.com - March 15 at 12:52 PM
msn.com logoAurobindo Pharma restarts aseptic product distribution; shares trade higher
msn.com - March 14 at 9:21 PM
marketbeat.com logoSei Investments Co. Reduces Position in Ascendis Pharma A/S (NASDAQ:ASND)
marketbeat.com - March 8 at 8:05 AM
finance.yahoo.com logoAscendis Pharma A/S (ASND) Faced R&D Setbacks in Q4
finance.yahoo.com - March 7 at 1:08 PM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) is RA Capital Management L.P.'s Largest Position
marketbeat.com - March 6 at 2:34 PM
marketbeat.com logoAdage Capital Partners GP L.L.C. Decreases Holdings in Ascendis Pharma A/S (NASDAQ:ASND)
marketbeat.com - March 5 at 1:20 PM
globenewswire.com logoAscendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024
globenewswire.com - March 4 at 8:30 AM
morningstar.com logoAscendis Pharma A/S ADR
morningstar.com - February 27 at 3:51 PM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) is Westfield Capital Management Co. LP's 4th Largest Position
marketbeat.com - February 26 at 11:32 AM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) Hits New 12-Month High at $161.00
marketbeat.com - February 26 at 10:51 AM
benzinga.com logo$1000 Invested In This Stock 15 Years Ago Would Be Worth $45,000 Today
benzinga.com - February 25 at 8:04 PM
marketbeat.com logoTimesSquare Capital Management LLC Buys 75,374 Shares of Ascendis Pharma A/S (NASDAQ:ASND)
marketbeat.com - February 25 at 11:54 AM
money.usnews.com logoAscendis Pharma A/S - ADR
money.usnews.com - February 22 at 7:52 PM
marketbeat.com logoCenterBook Partners LP Has $892,000 Stake in Ascendis Pharma A/S (NASDAQ:ASND)
marketbeat.com - February 21 at 8:38 AM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) Reaches New 52-Week High at $156.84
marketbeat.com - February 20 at 10:38 AM
marketbeat.com logoFmr LLC Sells 4,523 Shares of Ascendis Pharma A/S (NASDAQ:ASND)
marketbeat.com - February 20 at 7:31 AM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) Given Average Rating of "Moderate Buy" by Brokerages
marketbeat.com - February 19 at 3:41 AM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) Stock Position Trimmed by Baillie Gifford & Co.
marketbeat.com - February 17 at 9:19 AM
marketbeat.com logoShort Interest in Ascendis Pharma A/S (NASDAQ:ASND) Declines By 9.8%
marketbeat.com - February 16 at 2:33 PM
finance.yahoo.com logoAscendis Pharma A/S (ASND) is a Great Momentum Stock: Should You Buy?
finance.yahoo.com - February 15 at 5:45 PM
msn.com logoAre Medical Stocks Lagging Ascendis Pharma (ASND) This Year?
msn.com - February 15 at 12:45 PM
finance.yahoo.com logoAre Medical Stocks Lagging Ascendis Pharma (ASND) This Year?
finance.yahoo.com - February 15 at 12:45 PM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) Sets New 52-Week High at $146.00
marketbeat.com - February 13 at 12:56 PM
benzinga.com logoHow Is The Market Feeling About Ascendis Pharma?
benzinga.com - February 13 at 9:40 AM
marketbeat.com logoJ.P. Morgan Private Wealth Advisors LLC Makes New $1.81 Million Investment in Ascendis Pharma A/S (NASDAQ:ASND)
marketbeat.com - February 11 at 5:29 AM
finance.yahoo.com logoUS$172 - That's What Analysts Think Ascendis Pharma A/S (NASDAQ:ASND) Is Worth After These Results
finance.yahoo.com - February 10 at 8:41 AM
msn.com logoAscendis Pharma A/S Is Worried About This – Should You Be Worried Too?
msn.com - February 9 at 10:24 AM
marketbeat.com logoArtisan Partners Limited Partnership Reduces Holdings in Ascendis Pharma A/S (NASDAQ:ASND)
marketbeat.com - February 8 at 5:22 PM
realmoney.thestreet.com logoAscendis Pharma price target raised by $18 at Wedbush, here's why
realmoney.thestreet.com - February 8 at 2:01 PM
markets.businessinsider.com logoAscendis Pharma: Strong Buy on Robust Sales and Innovative Pipeline
markets.businessinsider.com - February 8 at 2:01 PM
finance.yahoo.com logoAscendis Pharma A/S (NASDAQ:ASND) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 8 at 2:01 PM
marketbeat.com logoAscendis Pharma A/S (NASDAQ:ASND) PT Raised to $182.00
marketbeat.com - February 8 at 11:53 AM
Get Ascendis Pharma A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASND and its competitors with MarketBeat's FREE daily newsletter.

Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

ASND Media Mentions By Week

ASND Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ASND
News Sentiment
▼
0.87

0.66
▲
Average
Medical
News Sentiment

ASND News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ASND Articles
This Week
▼
7

4
▲
ASND Articles
Average Week

Get Ascendis Pharma A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASND and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ASND) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Options trading has suddenly become more reliable.
Eagle Publishing
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press